semaglutide patent expiry 2031 The story: highlighting the need to maintain protection in Canada Semaglutide patent expiry opens door

Week 1: baseline disruption Most people begin GLP-1 therapy at the lowest available dose

GLP-1 in particular is responsible for communicating appetite, or lack thereof: When food arrives in the stomach, GLP-1 is generated to tell the pancreas to make more insulin, and also to tell the brain that food has been eaten so that it stops trying to find (and consume) more food

doi: 10.1172/JCI119060 61 TsengC-CZhangX-YWolfeMM

The idea is that the ingredients in the patch are absorbed through your skin and stimulate production of the natural hunger hormone GLP-1, which would make you feel full (though theres no evidence they can help with weight lossmore on that below)

Impacts on breast cancer survival and recurrence are still unclear